Tag Archives: tranparency

New Transparency in UK Pharma: A Bitter Pill to Swallow?

By Julian Upton | Published: January 18, 2011
In November 2010, members of the Association of the British Pharmaceutical Industry (ABPI) voted in favour of changes to its Code of Practice, with a view to breaking down ‘barriers to trust’ between healthcare professionals and the pharma. The amendments apply to clauses regarding consultant payments and meeting sponsorship. Under the new 2011 Code, pharma companies [...]
Posted in Europe, Global, Regulatory, compliance, healthcare | Also tagged , , , , | Leave a comment

Wins and Losses from Risk-Sharing Agreements

By William Looney | Published: November 17, 2010
Can you manage the external market impact? Risk-sharing agreements – where companies contract with reimbursement or assessment authorities to guarantee a new drug’s performance, often against specific outcomes measures, in return for access to patients – are among the latest innovations in managing health care costs. Use of the tool is standard in Australia, is [...]
Posted in Europe, Global, Regulatory, Strategy, healthcare, pricing | Also tagged , , , , , | Leave a comment